SCA acquires German BSN Medical will come as no surprise after the autumn speculation about just such a deal, but it’s happening now – when the company is facing a breakdown in two parts – is, perhaps, somewhat surprising.
the Price SCA the pay is not low, but not uncharacteristic for a company in the pharmaceutical sector.
It says Markku Jarvinen, analyst at Evli in Helsinki, the News agency Directly.
“Tajminen is somewhat surprising. They make such a large acquisition and takes the company in what is a new direction at the same time as the work of the division is going on, I had hardly expected me,” he says.
SCA announced on Monday morning that the company entered into an agreement to acquire the medical technology company BSN Medical from private equity firm EQT for 2.740 million euros, 26 billion of debt and kontantfri basis.
the Price means that SCA is paying over 3 times the 2015 sales and more than 20 times the adjusted operating income.
“It’s definitely not cheap, but not uncharacteristic for a company in the pharmaceutical sector”, says Markku Järvinen, who, however, points out that it can be discussed on the BSN, which produces products for compression, wound care and orthopedics – really should be viewed and valued as a pharmaceutical company.
the Acquisition means that SCA is embarking on for the company in new areas, says Markku Järvinen on.
“It’s about an acquisition, at eur 2.7 billion, which is expected to yield 30 million in synergies. It says something about how little akin business is with today’s SCA,” he says.
No comments:
Post a Comment